Navigation Links
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Date:8/6/2013

,529Deferred revenue, current portion 

3,4293,429Total current liabilities 

18,59725,114Deferred revenue, less current portion 

36,85738,571Other long-term liabilities 

--Commitments and contingenciesStockholders' equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at June 30, 2013 and December 31, 2012; noshares issued and outstanding atJune 30, 2013 and December 31, 2012--Common stock, $.001 par value, 300,000,000shares authorized at June 30, 2013 andDecember 31, 2012 and;97,962,987 and 84,413,670 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively

9884Additional paid-in capital 

518,024512,174Accumulated other comprehensive income (loss)

(1)15Accumulated deficit

(474,418)(436,804)Total stockholders' equity 

43,70375,469Total liabilities and stockholders' equity 

$
99,157$
39,154 

Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts)(Unaudited)Three Months Ended Six Months Ended June 30, June 30, 2013201220132012Revenues:Collaborative agreement $

857$

857$

1,714$

1,714License revenue ----Total revenues 8578571,7141,714Operating expenses:Research and development 13,09412,82228,24919,622General and administrative 6,0264,74211,1269,254Total operating expenses 19,12017,56439,37528,876Loss from operations (18,263)(16,707)(37,661)(27,162)Other income (expense):Interest income 17464889Interest expense --(1)(2)Total other income (expense) 17464787Net loss $

(18,246)$

(16,661)$

(37,614)$

(27,075)Net loss per share - basic and diluted $

(0.19)$

(0.25)$

(0.41)$

(0.40)Shares used in computing net loss per share – basic and diluted 94,98667,78
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014   Ventana Medical Systems, Inc. ... it has entered into an agreement with Merck KGaA, ... EMD Serono in the United States ... with Merck KGaA,s biopharmaceutical division on the development and ... target using Ventana,s proprietary diagnostic assays. In alignment with ...
(Date:7/10/2014)... R.I. , July 10, 2014 CVS Caremark ... board of directors has approved a quarterly dividend of $0.275 ... dividend is payable on August 1, 2014, to holders of ... CVS Caremark is dedicated to helping people ... pharmacy company in the United States . ...
(Date:1/15/2014)... DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com ... to its store . (Photo: ... consumption upgrade and policy support, China,s ... the years, with total market size rising from 3.28 ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... ,, NEW YORK , May 17 Reportlinker.com announces that a ... , , ... , , ... This report analyzes the ...
... 17 CareFusion (NYSE: CFN ), a leading, global ... Medegen, a leading innovator in clinically differentiated needleless access connectors and administration ... in cash. , , ... CareFusion is an industry leader in IV infusion devices with its Alaris® ...
Cached Medicine Technology:Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 2Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 3Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 4Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 5Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 6Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 7Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 8Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 9Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 10Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 11Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 12Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 13Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 14Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 15Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 16Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 17Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 18Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 19Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 20Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 21Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 22Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 23Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 24Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 25Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 26Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 27Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 28Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 29Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 30Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry 31CareFusion Completes Medegen Acquisition 2
(Date:7/11/2014)... Virginia (PRWEB) July 11, 2014 ASHBURN PSYCHOLOGICAL ... took effect, which allows individuals with an intellectual disability or ... of their licenses and ID cards to alert law enforcement ... a condition. The idea was inspired by a central ... in protecting her 9 year old autistic son, JP. ...
(Date:7/10/2014)... More than 200 experts on aggression, who research ... will attend the 21st World Meeting of the ... the Loews Atlanta Hotel, July 15-19. , Georgia ... which is held every other year on alternating continents. ... scholars from more than 20 different countries, which will ...
(Date:7/10/2014)... New York, US (PRWEB) July 10, 2014 ... . , Merrill DataSite recently streamed the live webinar ... featuring a discussion from a group of several M&A ... are seeing in the broader energy transaction marketplace. These ... hot and how the deal market in this sector ...
(Date:7/10/2014)... 10, 2014 A Forever Recovery ... gets clients off to a great start and gives ... in, has launched a new Eating Disorders section of ... section highlights:, , Different types of ... of Mental Disorders (DSM-IV), including anorexia nervosa, bulimia nervosa, ...
(Date:7/10/2014)... 2014 (HealthDay News) -- Nature, not nurture, may play ... chimpanzees, a new study finds. "As is the ... cognitive [thinking] abilities in chimpanzees," William Hopkins of the ... a news release from the journal Current Biology ... the evolution of intelligence in humans, Hopkins, team said. ...
Breaking Medicine News(10 mins):Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 3Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market 2Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:Like Humans, Chimps' Smarts May Rely on Genes 2
... research reports published in the new issue of Archives ... vascular birthmarks with treatment procedures like laser therapy and ... internal, or form an external birthmark and can be ... ,The researchers had presented the current treatment approaches for ...
... genetic disorder characterized by distorted, sickle shaped red blood cells. ... damage to the kidneys, spleen, and liver. The sickle cell ... is about 1 in 500., ,Despite much clinical work, ... can be relieved, and the frequency and duration of the ...
... Researchers at the University of California in San Francisco ... fruit and vegetables can reduce the risk of pancreatic ... most strongly associated with increased // protection were onions, ... potatoes, corn and yellow squash), dark leafy vegetables and ...
... medical journal The Lancet had published a research ... health workers., ,Poor health-worker performance is a ... In the current issue of The Lancet researchers ... for how high-quality health-worker performance can be achieved., ...
... Molecular Immunologist and his team has found a new virus ... inflammation and autoimmune diseases. The new delivery system acts as ... virus containing the required genes are transferred into the T ... the immune cells they get attracted towards the cancer cell ...
... have been reported to experience 25% less muscle and joint ... active. Furthermore, the study has also revealed that people who ... experience less pain than non-runners even though they are more ... study involved comparison of the level of pain in a ...
Cached Medicine News:Health News:Hydroxyurea Treatment For Children With Sickle Cell Disease 2
... helps you deliver unmatched performance through patient-focused ... the most complete anesthesia solution developed, putting ... - at your fingertips., ,The Aisys ... legacy of anesthesia delivery and patient monitoring ...
... Premilene Mesh LP Self-Forming Plug is combining ... This results in a very soft hernia plug ... to standard Plugs less foreign body material is ... the hernia size and shape allows for a ...
... Celsius Control System provides physicians,with ... safely,and rapidly lower patient body ... temperature and,rewarm patients to normothermic ... consists of an endovascular,catheter, console ...
... Fiberoptics Gemini surgical headlight is perfectly balanced ... durable and ultra-low-profile and illuminates brilliantly while ... annoying "rams effect." The fully adjustable headband, ... to sit low on the brow, directing ...
Medicine Products: